Expert opinion on the management of pain in hospitalised older patients with cognitive impairment: A mixed methods analysis of a national survey by Rodger, Kirsty T M et al.
Rodger et al. BMC Geriatrics  (2015) 15:56 
DOI 10.1186/s12877-015-0056-6RESEARCH ARTICLE Open AccessExpert opinion on the management of pain in
hospitalised older patients with cognitive
impairment: a mixed methods analysis of a
national survey
Kirsty TM Rodger1*, Corinne Greasley-Adams2, Zoe Hodge3 and Emma Reynish1,2Abstract
Background: Hospitalised older patients are complex. Comorbidity and polypharmacy complicate frailty. Significant
numbers have dementia and/or cognitive impairment. Pain is highly prevalent. The evidence base for pain management
in cognitively impaired individuals is sparse due to methodological issues. A wealth of expert opinion is recognised
potentially providing a useful evidence base for guiding clinical practice. The study aimed to gather expert opinion on
pain management in cognitively impaired hospitalised older people.
Methods: Consultant Geriatricians listed as dementia leads in the National Dementia Audit were contacted electronically
and invited to respond. The questionnaire sought information on their role, confidence and approach to pain
management in cognitively impaired hospitalised patients. Responses were analysed using a mixed methods approach.
Results: Respondents considered themselves very confident in the clinical field. Awareness of potential to do harm was
highly evident. Unequivocally responses suggested paracetamol is safe and should be first choice analgesic, newer
opiates should be used preferentially in renal impairment and nefopam is unsafe. A grading of the safety profile of
specific medications became apparent, prompting requirement for further evaluation and holistic assessment.
Conclusion: The lack of consensus reached highlights the complexity of this clinical field. The use of paracetamol first
line, newer opiates in renal impairment and avoidance of nefopam are immediately transferrable to clinical practice.
Further review, evaluation and comparison of the risks associated with other specific analgesics are necessary before a
comprehensive clinical guideline can be produced.
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Older patients in hospital are complex with co-morbidity,
polypharmacy and frailty being the norm. Pain is highly
prevalent. Although a subjective and personal experience,
pain is unanimously unpleasant with sensory and emo-
tional factors impacting on functional and mental capacity,
social interaction and quality of life [1]. Multiple physio-
logical and cognitive factors such as damaged nociceptive
pathways, lower pain thresholds and mood contribute to* Correspondence: kirstyrodger@nhs.net
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unless otherwise stated.the prevalence of pain in the elderly population. With
more disease (especially osteoarthritis), immobility, muscle
weakness and frequent falls persistent pain is common,
particularly chronic musculoskeletal pain. When pain is
coupled with cognitive impairment the impact and disabil-
ity is far greater [2].
Pain is no less frequent or intense in people with de-
mentia, with around 50% of these individuals experien-
cing pain regularly [3]. However studies have shown that
pain is often under recognised and under treated in the
cognitively impaired [2,4]. People with dementia are pre-
scribed and given less analgesia than other older people
[5]. When analgesia is prescribed to someone with de-
mentia 83% do not receive their medication [6] and 76%. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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post operatively for hip repair, despite 42% expected to
be in severe pain [7].
People with dementia may have difficulty in communi-
cating their pain and often care staff do not recognise
the non-verbal signs they may exhibit when in pain,
hence missing diagnostic clues [8]. Furthermore, reduc-
tion of semantic memory for pain seen in people with
dementia and reduced ability to identify pain is associ-
ated with a decline in pain reporting [9].
Pain may manifest itself differently in the cognitively
impaired and associated changes in behaviour may be at-
tributed to something other than pain leading to late or
misdiagnosis of pain [10,11]. The behavioural and psy-
chiatric symptoms of dementia are typically treated with
antipsychotics or sedatives which may be unnecessary
and harmful if the underlying stimulus such as pain is
recognised and treated accordingly. Ultimately untreated
pain is devastating in these individuals unable to explain
their pain [12]. Using a standardised protocol to treat
pain in nursing home residents with moderate to severe
dementia has been demonstrated to significantly im-
prove pain, agitation and aggression and could help re-
duce the unnecessary use of antipsychotics in people
with dementia [13].
Management of pain in older people and particularly the
cognitively impaired is challenging. Adverse drug reactions
are two to three times more common in older people than
younger individuals [14]. The risk of delirium is higher
and further augmented in those with existing cognitive
impairment whether due to vascular or degenerative brain
disease. Additionally, lack of recognition of side effects in
individuals with dementia may occur [15].
Despite recent publications regarding pain manage-
ment in older people such as that in Age and Ageing
[16], there is little specifically targeted at those with cog-
nitive impairment. It is accepted that clinical guidance
should be based on the best available evidence and that
from randomised controlled trials is gold standard. Due
to the complexity and heterogeneity of this elderly popu-
lation with cognitive impairment randomised controlled
trials are methodologically difficult, hence the evidence
base in this group is lacking. However we recognise the
wealth of expert opinion in this field. The aim of this
paper is to collate this opinion in order for it to be use-
ful in clinical practice.
Methods
We obtained a list of consultant Geriatricians/Dementia
Leads identified in the National Dementia Audit from
the British Geriatrics Society. This amounted to one
hundred contacts. We contacted them electronically
with an invitation to respond to a questionnaire relating
to their role, experience, confidence and opinions onpain management in elderly patients with cognitive im-
pairment. A second and third electronic message was sent
after two weeks and one month respectively as a reminder.
Their responses were anonymised. Ethical approval was
sought but the Local Research Ethics Committee advised
review was not necessary.
Those completing the questionnaire were presented
with three case scenarios (Additional file 1). They were
asked to provide an account of how they would manage
the case and what factors needed to be taken into con-
sideration in the management of such cases.
Analysis was undertaken in two parts. Responses to
closed questions (individuals’ confidence with the manage-
ment of each case scenario and their use of specific anal-
gesic medications) were analysed quantitatively. Thematic
analysis was undertaken of text responses. Comments
were grouped under common themes and reported find-
ings based on the common responses provided. The cod-
ing framework used was established from the responses
and was not pre-determined.
This work was supported by NHS Fife Endowments-
Geriatric Medicine Training Fund. This specifically
funded analysis and interpretation of data.
Results
Respondents
From the 88 individuals successfully contacted, 42
accessed and completed at least some part of the survey
(47.7% response rate). 5 were omitted from analysis due
to failure to complete the survey. Thus 37 responses
were included in the analysis. 73% of the respondents
worked at consultant level, 78% considered themselves
to be specialists in the management of delirium and 27%
were involved in a memory or specialist dementia clinic.
In all cases over 85% of respondents rated themselves
at 7 or above on a scale from 1 (not confident) to 10
(very confident) when asked to self-rate their confidence
in managing each case (Additional file 2).
Responses
There was no definite consensus of opinion on the man-
agement of each case or use of individual medication.
Respondents were aware of the potential to do harm
when prescribing medication and management sugges-
tions were cautious and exhaustive. Respondents’ replies
showed a number of key themes. These key themes will
now be discussed individually.
Use of analgesic medication
Response to case studies
In the free text replies regarding management of the
three case scenarios, there was overwhelming agreement
that paracetamol (orally/intravenously) should be the
first step in pain management.
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WHO pain ladder should be followed for subsequent
prescribing. The existence of further differentiation in
steps of the pain ladder (i.e. in the strength of analgesia
to be prescribed next) was not recognised with sugges-
tions including oxycodone, oramorph, codeine, bupre-
norphine, tramadol, NSAIDS and fentanyl. With each
suggestion respondents highlighted the need to consider
side effects and “balancing the need for analgesia with
the risk of opiate induced delirium”. In one case scenario
treatment with oxycodone was consensual due to co-
morbid chronic kidney disease. Specific comments per-
tained to codeine and its unpredictable metabolism.
Using codeine alongside paracetamol (in preference to
co-codamol) was considered preferable, allowing more
control over medication if side effects occurred. In some
cases despite canvasing opinion from specialists who
were highly confident in managing each scenario, re-
spondents’ opinions were completely in opposition to
each other e.g. whether to consider NSAIDS or not.
In addition to noting the potential for serious side ef-
fects respondents were also aware of the importance of
differing routes of administration, noting topical analgesia
is well tolerated. Also regular rather than PRN prescribing
of analgesia was deemed beneficial due to poor self-
reporting of pain.
Response to use of specific medication
When responding to the section of questionnaire exam-
ining use of specific medications the caution exhibited
in prescribing at the top end of the ladder was also in
evidence but a grading of the safety profile of individual
medications became apparent (Figure 1).Figure 1 Medication use by respondents in older people with cognitive imSpecific points raised by respondents included over-
whelming agreement that paracetamol should be the
first step in pain management since its efficacy is well
evidenced. It’s paucity of side effects was noted, in par-
ticular it was stated that it has no impact on cognition
and is well tolerated.
The weak opiates; co-codamol (avoided completely by
53%, used only with caution by 37%), codeine (avoided
completely by 28%, used only with caution in 64%) and
Dihydrocodeine (avoided by 57%, used only with caution
by 33%) were generally unpopular. Respondents recog-
nised that they often elicited unwanted side effects with
effects on cognitive and bowel function of particular
concern. If used, close monitoring and low dose titration
was recommended.
50% of respondents stated they would avoid using the
opiate Tramadol completely and 43% would only use
with extreme caution, recognising its potential to pre-
cipitate delirium.
The majority (91%) did suggest using morphine
sulphate. However they noted caution in prescribing due
to renal excretion and suggested checking renal function
prior to initiation and dose titrated to effect.
Treatment with oxycodone was considered to be a vi-
able option by the majority (77%). In their opinion it
had a favourable side effect profile compared to mor-
phine sulphate. Respondents particularly noted fewer
problems with accumulation of metabolites in patients
with renal impairment and it was felt to be less likely to
precipitate delirium.
Buprenorphine patches were considered a safe alterna-
tive to oral opioids and regarded as “renally friendly” but
slow onset of action hampered use in the acute setting.pairment.
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(76%) or avoided completely (21%). Under certain condi-
tions they should only be prescribed for a short period and
with PPI cover. Topical use was also considered.
Since amitriptyline is “not well tolerated even at low
doses” it was avoided by the majority (50%) and used
only with caution by 33%. It was noted to be particularly
useful for neuropathic pain but if used, only with caution
due to its high risk of causing delirium.
Of the gabapentinoids Pregablin was favoured over
Gabapentin. Low slow gradual dose titration was recom-
mended but again it was recognised that the class may
precipitate sedation and confusion.
Lidocaine plasters would be considered by the majority
(74%) for localised pain. There was conflicting opinion
of evidence base for non post herpetic neuralgia and it
was noted prescription restrictions apply in many areas
of the UK.
Fentanyl patches were also considered in patients who
demonstrated tolerance to equi-analgesic doses of other
opioids. Doses otherwise were felt to be too high for
most patients in this frail population. Toxicity was felt
to be a significant risk.
There was overwhelming agreement (80%) that nefo-
pam should not be used as an analgesic in this patient
population. Reasons for this included its anticholinergic
properties making it “notoriously deliriogenic”.
Need for further exploration
Over 70% of respondents in all cases highlighted the need
for further assessment and investigation. Suggested re-
quests included: more background and medical history for
the patient, identification of the cause of pain, identifica-
tion of delirium and treatment of its underlying cause,
multi-disciplinary assessment, early involvement of family/
caregivers, discussion of ongoing/anticipatory care, con-
sultation with specialist teams e.g. pain or palliative care
and the need to monitor pain and re-assess regularly.
Avoidance of harm
Over half of respondents provided comments coded under
this category. There was clear awareness of potential side
effects of pain medications. Suggestions pointed the need
to review and monitor patients for these especially by
screening and observing for delirium and opiate toxicity
but additionally by considering the impact of prescriptions
on renal and bowel function. The need to review existing
medications was highlighted with recommendations to pre-
vent accumulation and toxicity e.g. digoxin, or of stopping
some medication during the intercurrent illness causing the
pain e.g. withholding anti-hypertensives peri-operatively to
prevent acute kidney injury. There were also suggestions of
medications to be co-prescribed to prevent side effects
being experienced e.g. gastric protection in the use ofNSAIDs. Maintenance of hydration was also highlighted
as essential to protect renal and cardiac function when
treating pain.Need for monitoring and review
34 respondents (91.8%) commented that assessment and
re-assessment of pain was crucial. Approximately one
third of respondents (11) used clinical assessment alone
but others used established pain assessment tools e.g.
ABBEY (11), Doloplus (2), PAINAID (1), local (1).
The final themes highlighted the importance of the
environment and maintenance of overall health using the
principles of comprehensive geriatric assessment. This in-
cluded consideration of underlying cause of falls, screen-
ing for other causes of delirium and treating accordingly,
maintaining homeostasis of existing conditions, taking op-
portunity to rationalise existing medications and reduce
burden of polypharmacy.Discussion
The management of pain is a fundamental part of the
systematic and effective delivery of compassionate and
dignified care to older people. The experience of pain
can be disabling both physically and psychologically.
This is heightened in those with cognitive impairment
and/or dementia, yet high quality evidence to guide
management in this area is lacking. The synthesis of ex-
pert opinion in this study highlights the multi-faceted
complexity of pain management in this population and
significant potential for harm as a result of the analgesic
smorgasbord currently available to the clinician. The
preferences of respondents in this study do reflect the
principles outlined in the BGS standard [16] although it
only considered the management of pain in older people
in general not specifically those with cognitive impair-
ment. It also recognised the lack of well controlled stud-
ies in this population from which to base the evidence.
This study has many strengths; opinion was gathered
from experts across the UK. There was no pressure or
incentive for them to respond other than assisting the
common goal of improving patient care. The response
rate to the questionnaire was 48% and the majority of
respondents were very confident in the management of
these scenarios when asked to self-rate their confidence.
A mixed methods analysis was employed to capture the
nuances of individual clinicians approach to pain man-
agement. Limitations of the study however do include
the fact that results are based on expert opinion i.e. the
lowest grade of evidence, but as stated previously there
is an evidence gap in the management of pain in this
population. Despite the good response rate the total
number of respondents (37) is small.
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The lack of consensus that has resulted from this study
highlights the complexity of the clinical field when
managing pain in this population. The need for evalu-
ation of the whole individual (a Comprehensive Geriatric
Assessment approach), including their family and care-
givers and the environment are promoted rather than an
approach that would just simply treat the pain. The opin-
ion that the potential to do significant harm has come out
loud and clear in all responses: some medications are
more likely to cause harm than others and therefore evi-
dent that some are a more favourable option than others,
so despite no definite consensus the appearance of higher
risk and lower risk medications has become apparent.
Steps 2 and 3 on the WHO analgesic ladder are blurred in
this high risk population. The principles guiding the man-
agement of pain set out in the WHO pain ladder are ap-
plicable but as severity of pain increases, the choice of
analgesic becomes more difficult because of the facility to
do harm. A number of results are however unequivocal;
paracetamol is safe and should be the first choice analgesic
in this situation. Newer opiates should be used in prefer-
ence in renal impairment. There appeared to be caution
noted with prescription of codeine and tramadol. Nefopam
appears unsafe for use in this population. These points are
immediately transferrable to clinical practice but further
unpicking and comparison of the risks associated with
other specific analgesics in this population is necessary be-
fore a comprehensive clinical guideline can be produced.
The principles guiding pain management in this population
however are that individuals should be comprehensively
assessed and prescription of analgesia should be done with
a view to minimising resulting harm; using the principle of
“start low and go slow”.
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